| . | PMV (n = 17) . | Non-PMV (n = 34) . | P-Value . |
|---|---|---|---|
| Donor variables | |||
| Marginal donors (n) | 12 | 23 | 0.831 |
| Age >55 years (n) | 7 | 11 | 0.534 |
| Smoking history (>20 pack-years) (n) | 6 | 7 | 0.256 |
| PaO2/FiO2 ratio (mmHg), mean ± SD | 465 ± 72 | 469 ± 82 | 0.895 |
| PaO2 <300 mmHg (FiO2, 1.0 and PEEP, 5 cm H2O) (n) | 0 | 0 | 1.000 |
| Pulmonary infiltrates on CXR (n) | 6 | 15 | 0.546 |
| Purulent secretions on bronchoscopy (n) | 5 | 6 | 0.336 |
| Size matching (%), mean ± SD | 99.2 ± 15.1 | 101.4 ± 20.5 | 0.704 |
| Single lung transplantation | 97.8 ± 12.7 | 95.3 ± 22.5 | 0.749 |
| Bilateral lung transplantation | 102.6 ± 21.2 | 103.9 ± 19.6 | 0.896 |
| Operative variables | |||
| Transplantation type (n) | 0.005 | ||
| Single lung transplantation | 5 | 24 | |
| Bilateral lung transplantation | 12 | 10 | |
| Total ischaemic time (min), mean ± SD | 544 ± 115 | 453 ± 92 | 0.004 |
| ECMO use (n) | 15 | 13 | 0.001 |
| Postoperative variables (n) | |||
| Reoperation within 14 days after transplantation | 11 | 4 | <0.001 |
| Primary graft dysfunction | 2 | 1 | 0.255 |
| Acute rejection | 3 | 3 | 0.387 |
| . | PMV (n = 17) . | Non-PMV (n = 34) . | P-Value . |
|---|---|---|---|
| Donor variables | |||
| Marginal donors (n) | 12 | 23 | 0.831 |
| Age >55 years (n) | 7 | 11 | 0.534 |
| Smoking history (>20 pack-years) (n) | 6 | 7 | 0.256 |
| PaO2/FiO2 ratio (mmHg), mean ± SD | 465 ± 72 | 469 ± 82 | 0.895 |
| PaO2 <300 mmHg (FiO2, 1.0 and PEEP, 5 cm H2O) (n) | 0 | 0 | 1.000 |
| Pulmonary infiltrates on CXR (n) | 6 | 15 | 0.546 |
| Purulent secretions on bronchoscopy (n) | 5 | 6 | 0.336 |
| Size matching (%), mean ± SD | 99.2 ± 15.1 | 101.4 ± 20.5 | 0.704 |
| Single lung transplantation | 97.8 ± 12.7 | 95.3 ± 22.5 | 0.749 |
| Bilateral lung transplantation | 102.6 ± 21.2 | 103.9 ± 19.6 | 0.896 |
| Operative variables | |||
| Transplantation type (n) | 0.005 | ||
| Single lung transplantation | 5 | 24 | |
| Bilateral lung transplantation | 12 | 10 | |
| Total ischaemic time (min), mean ± SD | 544 ± 115 | 453 ± 92 | 0.004 |
| ECMO use (n) | 15 | 13 | 0.001 |
| Postoperative variables (n) | |||
| Reoperation within 14 days after transplantation | 11 | 4 | <0.001 |
| Primary graft dysfunction | 2 | 1 | 0.255 |
| Acute rejection | 3 | 3 | 0.387 |
CXR: chest X-ray; ECMO: extracorporeal membrane oxygenation; FiO2: fraction of inspired oxygen; PaO2: partial pressure of oxygen in arterial blood; PEEP: positive end-expiratory pressure; PMV: prolonged mechanical ventilation; SD: standard deviation.
| . | PMV (n = 17) . | Non-PMV (n = 34) . | P-Value . |
|---|---|---|---|
| Donor variables | |||
| Marginal donors (n) | 12 | 23 | 0.831 |
| Age >55 years (n) | 7 | 11 | 0.534 |
| Smoking history (>20 pack-years) (n) | 6 | 7 | 0.256 |
| PaO2/FiO2 ratio (mmHg), mean ± SD | 465 ± 72 | 469 ± 82 | 0.895 |
| PaO2 <300 mmHg (FiO2, 1.0 and PEEP, 5 cm H2O) (n) | 0 | 0 | 1.000 |
| Pulmonary infiltrates on CXR (n) | 6 | 15 | 0.546 |
| Purulent secretions on bronchoscopy (n) | 5 | 6 | 0.336 |
| Size matching (%), mean ± SD | 99.2 ± 15.1 | 101.4 ± 20.5 | 0.704 |
| Single lung transplantation | 97.8 ± 12.7 | 95.3 ± 22.5 | 0.749 |
| Bilateral lung transplantation | 102.6 ± 21.2 | 103.9 ± 19.6 | 0.896 |
| Operative variables | |||
| Transplantation type (n) | 0.005 | ||
| Single lung transplantation | 5 | 24 | |
| Bilateral lung transplantation | 12 | 10 | |
| Total ischaemic time (min), mean ± SD | 544 ± 115 | 453 ± 92 | 0.004 |
| ECMO use (n) | 15 | 13 | 0.001 |
| Postoperative variables (n) | |||
| Reoperation within 14 days after transplantation | 11 | 4 | <0.001 |
| Primary graft dysfunction | 2 | 1 | 0.255 |
| Acute rejection | 3 | 3 | 0.387 |
| . | PMV (n = 17) . | Non-PMV (n = 34) . | P-Value . |
|---|---|---|---|
| Donor variables | |||
| Marginal donors (n) | 12 | 23 | 0.831 |
| Age >55 years (n) | 7 | 11 | 0.534 |
| Smoking history (>20 pack-years) (n) | 6 | 7 | 0.256 |
| PaO2/FiO2 ratio (mmHg), mean ± SD | 465 ± 72 | 469 ± 82 | 0.895 |
| PaO2 <300 mmHg (FiO2, 1.0 and PEEP, 5 cm H2O) (n) | 0 | 0 | 1.000 |
| Pulmonary infiltrates on CXR (n) | 6 | 15 | 0.546 |
| Purulent secretions on bronchoscopy (n) | 5 | 6 | 0.336 |
| Size matching (%), mean ± SD | 99.2 ± 15.1 | 101.4 ± 20.5 | 0.704 |
| Single lung transplantation | 97.8 ± 12.7 | 95.3 ± 22.5 | 0.749 |
| Bilateral lung transplantation | 102.6 ± 21.2 | 103.9 ± 19.6 | 0.896 |
| Operative variables | |||
| Transplantation type (n) | 0.005 | ||
| Single lung transplantation | 5 | 24 | |
| Bilateral lung transplantation | 12 | 10 | |
| Total ischaemic time (min), mean ± SD | 544 ± 115 | 453 ± 92 | 0.004 |
| ECMO use (n) | 15 | 13 | 0.001 |
| Postoperative variables (n) | |||
| Reoperation within 14 days after transplantation | 11 | 4 | <0.001 |
| Primary graft dysfunction | 2 | 1 | 0.255 |
| Acute rejection | 3 | 3 | 0.387 |
CXR: chest X-ray; ECMO: extracorporeal membrane oxygenation; FiO2: fraction of inspired oxygen; PaO2: partial pressure of oxygen in arterial blood; PEEP: positive end-expiratory pressure; PMV: prolonged mechanical ventilation; SD: standard deviation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
